Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,241,983 papers from all fields of science
Search
Sign In
Create Free Account
continuous infusion
Known as:
Continuous Infusion Procedure
, infusion continuous
The administration of a fluid into a blood vessel, usually over a prolonged period of time.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A phase II (PhII) trial of sorafenib (S) in combination with 5-fluorouracil (5FU) continuous infusion (c.i.) in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary data.
I. Petrini
,
M. Lencioni
,
+7 authors
S. Ricci
Journal of Clinical Oncology
2016
Corpus ID: 30985425
4592 Background: S, an oral multi-kinase inhibitor that targets Raf-kinase and receptor tyrosine kinases, improved overall…
Expand
Review
2007
Review
2007
Comparison of the Pharmacokinetics of Piperacillin and Sulbactam during Intermittent and Continuous Intravenous Infusion
Julia Langgartner
,
N. Lehn
,
T. Glück
,
H. Herzig
,
Frieder Kees
Chemotherapy
2007
Corpus ID: 29850709
Background: The antibacterial effect of piperacillin/sulbactam depends on the time of drug concentration above the minimal…
Expand
2006
2006
Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections
C. Bidlingmaier
,
M. Deml
,
Karin Kurnik
Haemophilia
2006
Corpus ID: 24390323
Summary. Although the concept of continuous infusion (CI) of factor concentrates is well known, prospective paediatric data are…
Expand
2006
2006
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
R. Lewis
,
N. Wiederhold
,
R. Prince
,
D. Kontoyiannis
Journal of Antimicrobial Chemotherapy
2006
Corpus ID: 14748274
BACKGROUND Recent open label studies have suggested that dosing amphotericin B (AMB) by continuous infusion (CI) may reduce drug…
Expand
2001
2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study
M. Hunault-Berger
,
N. Milpied
,
+7 authors
N. Ifrah
Leukemia
2001
Corpus ID: 25796781
We report the first randomized study assessing the efficacy and safety of daunorubicin (DNR) continuous infusion (CI) compared to…
Expand
2000
2000
Activity of Gemcitabine and Continuous Infusion Fluorouracil in Advanced Pancreatic Cancer
D. Rauch
,
C. Maurer
,
+5 authors
M. Borner
Oncology
2000
Corpus ID: 25051603
Background/Objectives: Gemcitabine has been shown to improve survival and quality of life parameters compared to fluorouracil…
Expand
1999
1999
Pharmacodynamics of Intermittent- and Continuous-Infusion Cefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model
P. Tessier
,
D. Nicolau
,
C. Onyeji
,
C. Nightingale
Chemotherapy
1999
Corpus ID: 25826213
Cefepime, a fourth-generation cephalosporin, is currently one of the primary agents used in combination with an aminoglycoside…
Expand
1999
1999
PHARMACOKINETICS OF CONTINUOUS AND INTERMITTENT CEFTAZIDIME IN INTENSIVE CARE UNIT PATIENTS WITH NOSOCOMIAL PNEUMONIA
D. Nicolau
,
M. Lacy
,
J. McNabb
,
R. Quintiliani
,
C. Nightingale
1999
Corpus ID: 58115799
Intensive care unit patients with nosocomial pneumonia participating in a prospective, randomized trial comparing the efficacy of…
Expand
1999
1999
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
F. A. Scaraggi
,
V. De Mitrio
,
+4 authors
O. Schiraldi
Blood Coagulation and Fibrinolysis
1999
Corpus ID: 25698215
Recent studies have shown that treatment with a continuous infusion of recombinant activated factor VII (rFVIIa) is far more…
Expand
1995
1995
Continuous infusion fluorouracil/leucovorin and bolus mitomycin‐C as a salvage regimen for patients with advanced colorectal cancer
J. Conti
,
N. Kemeny
,
L. Saltz
,
A. McKenzie André
,
D. Grossano
,
J. Bertino
Cancer
1995
Corpus ID: 19600596
Background. No effective systemic salvage therapy exists for patients with advanced colorectal cancer who progress after…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE